As international opportunities for Canadian cannabis companies continue to expand in various countries, a research-focused company of cannabinoid-based therapies has officially announced its plans to enter the Colombian market.

On Monday (April 9) Scythian Biosciences (TSXV:SCYB; OTCQB:SCCYF), unveiled its intentions to acquire MMJ Colombia Partners, a company embedded in the medical cannabis market for Colombia currently expanding that footprint.


Following completion of the deal, Scythian will be the sole shareholder of MMJ Colombia and MMJ’s most recent acquisition in process. MMJ Colombia is taking steps to acquire 90 percent of the issued and outstanding shares of Colombian company ColCanna.

The terms of this acquisition make it dependant on the completion of MMJ Colombia’s acquisition of ColCanna and to fully acquire Colombian licenses for the cultivation, production, research, and export of medical cannabis CBD and THC extracts.

“With a climate that allows four harvests a year, we can now expand our production, research and retail of the highest quality cannabis products in Colombia and the world,” Jonathan Gilbert, Scythian CEO said.

As part of the acquisition, Scythian also detailed a variety of considerations, including an advance of US$1.2 million of the purchase price in cash, once receiving ColCanna’s final licenses. According to its announcement, Scythian will also:

Issue on the closing date CDN$32,000,000 of common shares in the capital of Scythian (the “Common Shares”) at an issue price equal to the volume weighted average price of the Common Shares over the 20 trading days prior to the closing date of the Acquisition, provided that no less than 1,570,000 Common Shares will be issued as share consideration.

Scythian will also issue US$5 million of non-interest bearing, unsecured promissory notes due at specific dates all throughout 2018 and into next year.

As previously reported by the Investing News Network (INN) the Colombian cannabis market has provided an option of growth for companies raising funds through the Canadian stock exchanges.

Alvaro Torres, president, and CEO of Khiron Life Sciences–a company seeking to offer its stock in Canada–told INN the Colombian market is too attractive for other producers to let go.

“In the end, we have to look for bigger markets and all the LPs (licensed producer) are looking at the way that they can continue opening up their well-known strategies and well-known cultivation activities into a market that is just opening up, which is Colombia,” Torres said.

“As more countries legalize cannabis for medicinal use, Colombia is positioned to become a dominant supplier to these new countries as they ramp up their own domestic production capacity,” Ryan Douglas a cannabis growth consultant told Marijuana Business Daily.

In an interview with INN, Neil Closner, CEO of MedReleaf (TSX:LEAF) previously said he believes the international market for medical cannabis is the biggest option available for medically focused companies.

“[T]here are a lot of countries that are advancing legislation to legalize medical cannabis… and many of those countries are more medically focused and medical rigorous than even Canada is today,” he said.

Closner added the countries he references already have cannabis covered for medical purposes as part of their insurance coverage.

Investor takeaway

It will be key for Scythian shareholders to watch on the development of ColCanna’s acquisition by MMJ Colombia and the status of the licenses for the local company as a deal fallout has proven to sour the markets.

As of 3:07 p.m. EST on Monday, Scythian’s share price on the TSX Venture exchange declined 10.55 percent. The company is currently valued at C$16.28 per share.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:

  • Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
  • 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
  • Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.

About Cresco Labs

Keep reading... Show less

Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.

Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.

Keep reading... Show less

All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.

Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.

Keep reading... Show less

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.

As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.

Keep reading... Show less

As Canadian operators race to strengthen their positions in the cannabis landscape, are international pursuits outside North America still top of mind?

The role that mergers and acquisitions (M&A) have played in the expansion of Canadian companies across the globe has been monumental for the growth of the cannabis industry. Now the space has reached a critical point as the demands of the US market increase.

Keep reading... Show less